Intelligence Search Intelligence Filter by: Industry Team Airport & AviationAutomotiveEmerging TechnologiesEnergy Food & BeverageHealth CareHospitality, Resort & GolfInsurance & Reinsurance Life SciencesManufacturingMedical DevicesSports Practice Area Business Law All Business LawEmployee Benefits & Executive CompensationEnvironmental RegulationEstates & TrustsFinance & Financial InstitutionsHealth Care Finance Private Equity & Venture CapitalPublic FinanceReal EstateSecurities, Commodities & Exchange RegulationTaxationTransactional & Securities Government & Public Policy All Government & Public PolicyFDA RegulatoryFederal & State Energy RegulatoryFreight & Commuter RailGovernment Procurement Immigration, Nationality & Consular LawNHTSA & Motor Vehicle SafetyPolitical LawPublic Policy Intellectual Property All Intellectual PropertyBusiness Method & Software PatentsChemical, Biotechnology & PharmaceuticalElectronicsGreen Energy TechnologiesInformation Technology & Outsourcing IP Due DiligenceIP LitigationMechanical & Electromechanical TechnologiesPatent Office TrialsTrademark, Copyright & Advertising Counseling International All InternationalChina EuropeJapan Litigation All LitigationAntitrustAppellateBankruptcy & Business ReorganizationsBusiness Litigation & Dispute ResolutionConstructionConsumer Financial Services Distribution & FranchiseGovernment Enforcement, Compliance & White Collar DefenseInsurance & Reinsurance LitigationLabor & EmploymentPrivacy, Security & Information ManagementSecurities Enforcement & LitigationTrade Secret Noncompete Litigation Topic Accountable Care OrganizationsAmerica Invents Act (Patent Reform)Consumer Protection Act Corporate GovernanceDodd–Frank Wall Street ReformExport Control/Economic Sanctions Foreign Corrupt Practices Act (FCPA)Health Care ReformPersonalized Medicine Type ArticleBlog Post BookNewsletter VideoWhite Paper Featured All Filters applied: Search phrase entered: Sort results by: Most Recent Most Viewed Most Shared Foley Blogs: CFSL Bulletin Cleantech & Nano Dashboard Insights Labor & Employment Law Perspectives Personalized Medicine Bulletin PharmaPatents Renewable Energy Outlook Wisconsin Appellate Law Medical Device Industry Responds to FDA's Overseas Clinical Trial Proposed Rule 16 June 2013 Personalized Medicine Bulletin Guest Post By Jennifer M. Forde, Nathan A. Beaver and David L. Rosen In a resounding manner, members of the medical device industry recently filed comments reacting... FDA's Plan to Regulate LDTs 14 June 2013 Personalized Medicine Bulletin Guest Post By David L. Rosen and Nathan A. Beaver In a remarkable move, the Food and Drug Administration recently indicated that it plans to take new steps to... U.S. Patent "Micro-Entity" Rules & Other Cost Savings Strategies: Do You qualify for 75% Off Your U.S. Patent Filing Costs? 12 June 2013 Cleantech & Nano The short answer is that a company or individual who already is qualified as a small entity (which entitles you to 50% off U.S. patent filing... Nanomedicine Hitting Its Stride? Beware of Patent Risks 31 May 2013 Cleantech & Nano Though the first nanoparticulate drug formulation was approved by the U.S. FDA way back in 1995, a recent flurry of deals and product approvals have shown increasingly... Will the Supreme Court Limit Nanotech Patents? 31 May 2013 Cleantech & Nano In a case styled The Association for Molecular Pathology v. Myriad Genetics, the Supreme Court is confronting the question of whether or not human genes are patent... FDA Regulation of Laboratory Developed Tests: Benefit or Unnecessary Burden? 24 February 2013 Personalized Medicine Bulletin The U.S. Department of Food and Drug Administration (“FDA”) has previously announced an interest in regulating diagnostic tests used in providing personalized medicine... FDA Issues Draft Guidance for Clinical Trials Using Enrichment Strategies 07 January 2013 Personalized Medicine Bulletin The Food and Drug Administration (FDA) recently issued a guidance document related to the conduct of clinical trials to support approval of human drugs and biological... Related 1 2 3
Medical Device Industry Responds to FDA's Overseas Clinical Trial Proposed Rule 16 June 2013 Personalized Medicine Bulletin Guest Post By Jennifer M. Forde, Nathan A. Beaver and David L. Rosen In a resounding manner, members of the medical device industry recently filed comments reacting...
FDA's Plan to Regulate LDTs 14 June 2013 Personalized Medicine Bulletin Guest Post By David L. Rosen and Nathan A. Beaver In a remarkable move, the Food and Drug Administration recently indicated that it plans to take new steps to...
U.S. Patent "Micro-Entity" Rules & Other Cost Savings Strategies: Do You qualify for 75% Off Your U.S. Patent Filing Costs? 12 June 2013 Cleantech & Nano The short answer is that a company or individual who already is qualified as a small entity (which entitles you to 50% off U.S. patent filing...
Nanomedicine Hitting Its Stride? Beware of Patent Risks 31 May 2013 Cleantech & Nano Though the first nanoparticulate drug formulation was approved by the U.S. FDA way back in 1995, a recent flurry of deals and product approvals have shown increasingly...
Will the Supreme Court Limit Nanotech Patents? 31 May 2013 Cleantech & Nano In a case styled The Association for Molecular Pathology v. Myriad Genetics, the Supreme Court is confronting the question of whether or not human genes are patent...
FDA Regulation of Laboratory Developed Tests: Benefit or Unnecessary Burden? 24 February 2013 Personalized Medicine Bulletin The U.S. Department of Food and Drug Administration (“FDA”) has previously announced an interest in regulating diagnostic tests used in providing personalized medicine...
FDA Issues Draft Guidance for Clinical Trials Using Enrichment Strategies 07 January 2013 Personalized Medicine Bulletin The Food and Drug Administration (FDA) recently issued a guidance document related to the conduct of clinical trials to support approval of human drugs and biological...